CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 17 enrolled
Drug / intervention
Extracellular Matrixdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01292876
NCT01292876N/ACompleted
CompareCT.gov

Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) With the Use of Biologic Scaffolds for Patients Suffering From Severe Skeletal Muscle Injury

University of Pittsburgh·interventional·Posted Feb 10, 2011·Updated Dec 7, 2020

In Brief

A clinical study evaluating Extracellular Matrix for Traumatic Injury and 4 related conditions. Completed, enrolled 17 participants across 2 sites.

Detailed Summary

The objective of the study is to assess mechanical strength and function in subjects undergoing Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) with the use of biologic scaffolds for the restoration of both mechanical strength and function in these subjects. This study formally evaluated healing and return of function after an extracellular matrix device implantation in 17 male and female subjects participating at the University of Pittsburgh under the Department of Plastic and Reconstructive Surgery who suffer from injury with loss of skeletal muscle tissue.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTraumatic Injury, Muscle Injury, Tendon Injury, Soft Tissue Injury, Extremity Injury
CountriesUnited States
CollaboratorsUnited States Department of Defense

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 10, 2011
Enrollment StartDec 1, 2010
Primary CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 15.4 years ago

Interventions

Extracellular Matrixdevice

Extracellular Matrix